The Medication-Diabetes Connection
The VA Mental Health system treats hundreds of thousands of veterans for PTSD every year, and the pharmaceutical backbone of that treatment often includes atypical antipsychotic medications — drugs like quetiapine (Seroquel), olanzapine (Zyprexa), and risperidone (Risperdal). These medications are genuinely effective for managing certain aspects of PTSD, including hyperarousal, sleep disruption, and intrusive thoughts. But they carry a metabolic cost that is both clinically significant and well-documented in the medical literature: they cause weight gain, insulin resistance, metabolic syndrome, and, in a substantial proportion of patients, Type 2 diabetes.
The FDA has required black-box warnings on atypical antipsychotics for their metabolic effects for over a decade. These are not rare side effects or theoretical risks — they are common, expected, and documented outcomes that prescribers are trained to monitor for. The American Diabetes Association and American Psychiatric Association jointly published guidelines specifically addressing the need to monitor blood glucose and lipids in patients on these medications. The causal relationship between atypical antipsychotics and metabolic syndrome is established medical consensus, not a disputed theory.
For veterans, this creates a straightforward secondary service connection argument: service-connected PTSD led to a VA prescription for an atypical antipsychotic, the medication caused metabolic syndrome and Type 2 diabetes, and therefore the diabetes is a secondary service-connected condition under 38 CFR § 3.310. The veteran did not choose the medication — the VA prescribed it. The resulting metabolic damage is a consequence of treating a service-connected condition.
VA pharmacy data consistently shows atypical antipsychotics among the most prescribed medications in the VA system, with quetiapine being particularly prevalent in PTSD treatment regimens. Studies of veterans with PTSD on long-term atypical antipsychotic therapy show metabolic syndrome rates significantly higher than the general veteran population not on these medications.
Which Medications Carry the Highest Metabolic Risk
Not all psychiatric medications carry the same metabolic risk profile. Understanding which drugs are most implicated helps veterans and their providers frame the nexus argument on the most solid scientific ground.
Clozapine is also high-risk but is less commonly prescribed outside of severe treatment-resistant cases. Aripiprazole (Abilify) and ziprasidone are considered metabolically neutral and are generally not the basis for a diabetes secondary claim.
The key evidence for your claim is the specific medication prescribed, the dosage, and the duration of use relative to the onset of metabolic abnormalities. A veteran who was prescribed quetiapine 200–400mg nightly for five years for PTSD-related sleep and then developed pre-diabetes and subsequently Type 2 diabetes during that period has a strong temporal and pharmacological foundation for a secondary claim.
The Legal Service Connection Chain
Under 38 CFR § 3.310, secondary service connection extends to conditions caused by the medical treatment of a service-connected condition — not just conditions directly caused by the service-connected condition itself. This is the medication pathway theory, and the VA's own regulations support it. The legal chain is:
The Service Connection Chain
The critical legal point is that the veteran did not choose this medication. They did not seek out a drug known to cause diabetes. They complied with their VA provider's treatment plan for a service-connected condition. The metabolic consequences that followed are a direct result of that treatment. Courts and the Board of Veterans' Appeals have consistently held that injuries or conditions arising from the treatment of service-connected conditions are themselves service-connected.
DC 7913 Rating Criteria for Type 2 Diabetes
Diabetes Mellitus, Type 2 is rated under Diagnostic Code 7913. Understanding the rating criteria allows you to frame your evidence to establish the highest applicable rating based on your actual functional limitations and treatment requirements.
| Rating | Criteria | 2025 Monthly Compensation* |
|---|---|---|
| 10% | Manageable by restricted diet only; no medication required | ~$175/mo |
| 20% | Requires insulin or oral hypoglycemic medication; OR, restricted diet | ~$342/mo |
| 40% | Requires insulin AND restricted diet AND regulation of activities | ~$757/mo |
| 60% | Requires insulin AND restricted diet AND regulation, with episodes of ketoacidosis or hypoglycemic reactions requiring hospitalization or parenteral medication at least once per year | ~$1,361/mo |
| 100% | Requires more than one daily injection of insulin, restricted diet, regulation of activities; plus either frequent episodes of ketoacidosis or hypoglycemia, or progressive loss of weight and strength | ~$3,831/mo |
*Approximate 2025 rates, single veteran, no dependents. Actual combined rating will affect monthly compensation.
A few practical notes on DC 7913 ratings:
- "Regulation of activities" means the veteran must avoid physically strenuous activities due to diabetes management requirements — not simply that they are tired. Your medical records and treating physician's notes should document any activity restrictions related to hypoglycemia risk or other diabetes management needs.
- Oral hypoglycemic medications (metformin, glipizide, semaglutide/Ozempic, etc.) qualify for the 20% minimum rating. If you are on any diabetes medication, you meet the 20% threshold.
- Hypoglycemic episodes should be documented in your medical records whenever they require treatment intervention. An episode serious enough to require glucagon injection, emergency services, or hospitalization documents the 60% threshold.
The Weight Gain and Obesity Claim
Before diabetes develops — and often concurrently — psychiatric medications cause significant weight gain and obesity. This creates a separate, independent claim pathway that many veterans miss entirely.
Obesity itself can be rated as a secondary condition when it is caused by a service-connected condition or its treatment. While the VA historically has been resistant to rating obesity directly, the legal theory is established: medication-induced weight gain that results in clinically significant obesity, with measurable functional impairment (limited mobility, joint stress, breathing difficulty), constitutes a ratable disability secondary to the medication, which is secondary to the service-connected PTSD.
More importantly, obesity caused by psychiatric medications creates its own chain of secondary conditions:
- Obstructive sleep apnea secondary to medication-induced obesity — DC 7302, ratable at 30%, 50%, or 100%
- Hypertension secondary to metabolic syndrome — DC 7101, ratable at 10%, 20%, 40%, or 60%
- Hyperlipidemia and cardiovascular disease secondary to metabolic effects — DC 7005 (coronary artery disease)
- Musculoskeletal strain from excess weight — joint damage ratings
The strategic approach is to document the weight gain timeline precisely: note your weight before starting the medication, the weight increase during the medication period, and any comorbid conditions that developed or worsened during the same period. VA prescription records showing the medication start date combined with body weight measurements from VA appointments create a compelling evidentiary timeline.
If you started quetiapine in 2017 for PTSD, gained 40 pounds between 2017 and 2020, had your first elevated HbA1c in 2019, and received a Type 2 diabetes diagnosis in 2021 — that timeline tells the story without needing elaborate arguments. The medical record itself demonstrates the causal sequence.
Evidence You Need to Win This Claim
Complete Evidence Checklist
- VA prescription records for psychiatric medications: Obtain your complete VA pharmacy records showing the medication name, dosage, prescribing date, and prescribing diagnosis (PTSD or depression). This establishes that the medication was prescribed for a service-connected condition. Request these through MyHealtheVet or a VA records request.
- VA medical records documenting metabolic monitoring: Most VA providers are supposed to monitor lipids and blood glucose when prescribing atypical antipsychotics. These records may already show your metabolic trajectory — rising HbA1c, weight gain, lipid abnormalities — all documented within the VA system before your diabetes diagnosis.
- Diabetes diagnosis records: Clinical documentation of the Type 2 diabetes diagnosis — the specific HbA1c or fasting glucose value, the date, the treating provider. This is the foundational "disability exists" evidence.
- Endocrinologist or internist evaluation: A specialist who evaluates your diabetes management, documents your current treatment requirements (oral medications, insulin, dietary restrictions, activity restrictions), and can write a nexus letter linking the diabetes to the medication's metabolic effects.
- FDA prescribing information for the specific medication: The FDA black-box warning and prescribing information section on metabolic effects is publicly available and should be referenced in your nexus letter. It establishes that even the manufacturer acknowledges the causal relationship between the medication and metabolic syndrome.
- Nexus letter from endocrinologist or internist: The capstone document linking your specific diabetes diagnosis to the metabolic side effects of the specific medication prescribed for your service-connected PTSD.
- Timeline documentation: A chronological summary showing (a) PTSD service connection date, (b) medication start date, (c) first metabolic abnormality documented, (d) obesity/weight gain documented, (e) diabetes diagnosis date. This can be prepared by you or your VSO.
Exact Nexus Letter Language
The nexus letter for this claim must bridge the causal chain across multiple steps — from PTSD to medication to metabolic effects to diabetes. Here are template frameworks for your treating provider:
Standard nexus letter — endocrinologist or internist:
"I have reviewed [Veteran's name]'s medical history, including VA pharmacy records documenting prescription of [quetiapine/olanzapine] for service-connected PTSD beginning [date]. Veteran's medical records demonstrate progressive weight gain of [X] pounds and sequential HbA1c elevations from [baseline] to [current value] during the period of medication use, consistent with the well-documented metabolic effects of atypical antipsychotic medications. It is my medical opinion that Veteran's Type 2 Diabetes Mellitus is at least as likely as not caused by, or aggravated by, the metabolic side effects — specifically insulin resistance and weight gain — associated with [medication name] prescribed for service-connected PTSD. This opinion is supported by FDA-recognized metabolic risks of this medication class, the established temporal relationship between medication initiation and metabolic deterioration in this veteran's medical record, and the absence of other clinically significant risk factors that would more plausibly explain the onset of Type 2 diabetes at Veteran's age."
Aggravation theory (for pre-existing diabetes that worsened):
"Veteran had a prior diagnosis of pre-diabetes/Type 2 diabetes prior to starting [medication]. Medical records document significant worsening of glycemic control — [specific HbA1c values] — during the period of [medication] use, requiring escalation from [prior treatment] to [current treatment]. It is my medical opinion that Veteran's service-connected PTSD treatment with [medication] aggravated the pre-existing diabetes beyond its natural progression, within the meaning of 38 CFR § 3.310, by causing drug-induced insulin resistance superimposed on the pre-existing condition."
Downstream Secondary Conditions From Diabetes
A successful diabetes secondary claim is not the end of the story — it is the beginning of another layer of secondary conditions. Diabetes is one of the most prolific generators of separately ratable complications in the entire VA system. Each complication flows from the diabetes, which flows from the medication, which flows from the PTSD. All are potentially service-connected.
Each downstream condition requires its own secondary claim filing and nexus letter. The nexus chain in these cases has an extra link: the condition is secondary to the diabetes, which is secondary to the medication, which is secondary to PTSD. VA regulations support this multi-link chain — conditions secondary to secondary conditions are compensable as long as each causal link can be established with medical evidence.
- File for the diabetes now, while it is in early stages — the rating is lower but the service connection is established
- If complications develop later, you file a claim for increased rating and add the new conditions as secondary to the established diabetes rating
- Establishing service connection early locks in your effective date, which can affect retroactive back pay if your rating increases over time
The PACT Act Angle
The PACT Act of 2022 dramatically expanded presumptive service connection for toxic exposure conditions and also addressed burn pit and other exposure-related conditions. For veterans who served in burn pit areas and have diabetes, there may be an additional pathway: some research has linked certain chemical exposures to metabolic disruption and increased diabetes risk.
More directly relevant: if your PTSD itself is being claimed or re-evaluated under PACT Act provisions (expanded combat presumptions), ensuring that your psychiatric medication prescription is tied to that PTSD claim strengthens the medication bridge. Use our PACT Act eligibility tool to identify whether you have additional exposure-based claim pathways that might strengthen your underlying PTSD rating — which in turn strengthens the secondary chain for your diabetes claim.
Estimate Your Diabetes + Secondary Conditions Rating
Add your diabetes, neuropathy, and metabolic secondary conditions to your combined rating calculation and see the full financial picture.
Estimate My Rating Check PACT Act EligibilityAction Steps for Veterans
- Obtain your complete VA prescription history. Log into MyHealtheVet or submit a VA Form 10-5345 (Request for and Consent to Release of Medical Records) to obtain your full pharmacy records. Identify every atypical antipsychotic, SSRI, or other psychiatric medication ever prescribed, with start dates, dosages, and prescribing diagnoses.
- Review your VA lab records for metabolic trends. VA labs document blood glucose, HbA1c, cholesterol, and weight at each primary care visit. Request these records and create a timeline from the date your psychiatric medication was started to the present. The metabolic deterioration pattern in those numbers is your foundational evidence.
- Get a current endocrinology evaluation. If you have not seen an endocrinologist, request a referral through your VA PCP. The endocrinologist's evaluation documents your current diabetes management requirements — which determines your rating level under DC 7913.
- Ask your endocrinologist or internist to write a nexus letter using the template language above. Most VA-enrolled physicians are familiar with VA nexus letters and willing to write them for veterans; some may need a bit of guidance on the specific language required.
- File VA Form 21-526EZ listing Type 2 Diabetes Mellitus (DC 7913) as a new condition secondary to service-connected PTSD, via the medication pathway. Attach your nexus letter, prescription records, and lab timeline.
- Simultaneously evaluate downstream conditions. At the same visit with your endocrinologist, request evaluation for peripheral neuropathy, retinopathy, and kidney function — the three most common and most ratable diabetes complications. If any are present, file secondary claims for those conditions at the same time.
- Use our Combined Rating Calculator to model how your diabetes rating — plus any downstream secondary conditions — affects your overall combined disability percentage and monthly compensation.
Unlike many secondary claims that require complex nexus arguments, the medication-to-diabetes chain is supported by FDA black-box warnings, VA's own clinical monitoring guidelines, and decades of peer-reviewed literature. A well-documented nexus letter tying your specific medication to your specific metabolic trajectory is often sufficient to win this claim at the initial decision level — without an appeal.
The VA treated your PTSD with a medication that carries a known, federally recognized risk of causing Type 2 diabetes. You complied with your treatment. You followed your provider's instructions. And if diabetes followed, that is not your fault — and it is not a condition you should bear without compensation.
The law supports this claim. The medical evidence supports this claim. The only thing standing between you and a Type 2 diabetes rating — and all the downstream secondary conditions it opens the door to — is the decision to file it.
Ready to File Your Diabetes Secondary Claim?
Build your full secondary service connection claim — from PTSD to medication to metabolic syndrome to diabetes — step by step with our claim builder.
Start Your Claim → Calculate My Combined Rating